What is Ortho-K?
Orthokeratology is a treatment where a nearsighted, or myopic, patient places custom designed lenses in their eyes just before going to sleep. These special lenses gently mold the front surface of the cornea (the clear part of the eye that conventional contacts rest on) to correct the patient’s vision. The lenses are removed upon wakening, and contacts/glasses are then no longer needed during the daytime!
Is this surgery?
No. This is a gentle molding of the cornea.
Is Ortho-K reversible?
100% reversible upon discontinuation of the treatment
Is the treatment safe?
Absolutely, under the care of a certified Orthokeratologist. Dr. Neukirch is one of the few Chicagoland doctors that fit a large number of Ortho-K patients. He is a member of the Orthokeratology Academy of America (OAA) and will only use materials and designs that are FDA approved. Dr. Neukirch is happy to speak with your doctor or pediatrician should they have any questions before you or your child starts this treatment.
Not entirely. Ortho-K has been around since the 1960’s. Ortho-K has historically been very popular in Asian countries, where myopia was much more prevalent. Recent advancements in computerized instrumentation and lens design has yielded dramatically improved results and thus it’s recent rise in popularity in the United States.
Can Ortho-K keep your eyes from getting worse?
Myopia typically progresses until a patient reaches 20 to 25 years of age. If Ortho-K is initiated before that time, peer-reviewed clinical research indicates that the treatment may slow this progression; sources are cited at the end of this article.
Why am I only hearing about this now?
Multiple reasons: 1.) The first and only FDA approved treatment was Paragon CRT only a few years prior. 2.) Myopia has become much more prevalent in the United States within the past twenty years. 3.) The clinical research which confirms the link between Ortho-K and delayed progression of myopia has only been published in the last couple of years (sources cited below).
Has anyone at Carillon undergone Ortho-K?
Hundreds of patients. Ask around at your child’s school, chances are there are multiple Carillon Ortho-K patients that are glasses-free.
Am I a candidate?
The best candidates for Ortho-K are myopic children and teenagers, whose eyes are still changing. However, adults can make great candidates in many circumstances, too. Unfortunately, certain prescriptions and corneal shapes may exclude patients from utilizing this treatment.
Simply inquire at your next exam, call our office, or make an appointment with Dr. Neukirch online (Dr. DalPorto does not perform Ortho-K). Our doctors can review your chart to see if Ortho-K is a possibility for you or your children. Ortho-K consultations are completely free of charge, if the patient has received a comprehensive eye exam at our office within the past year. Otherwise regular exam fees apply (again, the consultation part of the exam is complimentary).
Where can I find more information?
In addition to the journal articles below, Paragon CRT has a great patient website at www.CRTvision.com. We also have pamphlets available at the Carillon front desk. Please feel free to email Dr. Neukirch directly at firstname.lastname@example.org with any questions.
Dr. Andrew Neukirch practices at Carillon Vision Care located in Glenview, Illinois.
Effect of Orthokeratology on myopia progression: twelve-year results of a retrospective cohort study. Yueh-Chang Lee, Jen-Hung Wang, and Cheng-Jen Chiu. BMC Ophthalmology. 2017; 17: 243. December 2017.
Myopia control in children through refractive therapy gas permeable contact lenses: is it for real? Koffler BH, Sears JJ. American Journal of Ophthalmology. December 2013.
Myopia Control with Orthokeratology Contact Lenses in Spain: Refractive and Biometric Changes. Jacinto Santodomingo-Rubido, César Villa-Collar, Bernard Gilmartin and Ramón Gutiérrez-Ortega. Investigative Ophthalmology and Visual Science. July 2012.
Trial. Pauline Cho and Sin-Wan Cheung. Investigative Ophthalmology and Visual Science. October 2012.